FDA Approves EVOLENCEŽ, A New Generation Collagen Based Facial Filler
Jul 4th 2008Drug InformationDermatology
The U.S. Food and Drug Administration (”FDA”) announced the approval of EVOLENCEŽ for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds. EVOLENCEŽ is a new advanced collagen-based structural dermal filler, and a first of its kind product. The introduction of EVOLENCEŽ marks the first dermal filler entry for the Aesthetics Group of OrthoNeutrogena.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
